Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

110.15
-0.2750-0.25%
Post-market: 110.180.0350+0.03%19:10 EST
Volume:946.24K
Turnover:103.84M
Market Cap:28.53B
PE:-39.37
High:110.89
Open:109.19
Low:108.65
Close:110.42
52wk High:124.00
52wk Low:81.20
Shares:259.03M
Float Shares:104.00M
Volume Ratio:1.85
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7976
EPS(LYR):-2.8652
ROE:-3.04%
ROA:-2.30%
PB:1.31
PE(LYR):-38.44

Loading ...

BioNTech Sues Moderna Over COVID-19 Vaccine Technology Patent

MT Newswires Live
·
Feb 20

Overnight Market Update: US Stocks Decline, Oil and Gold Advance, Trump Issues Iran Ultimatum, UK's Former Prince Andrew Released

Deep News
·
Feb 20

BioNTech’s New HIV Antibody Trial Adds Depth to BNTX’s Long-Term Pipeline Story

TIPRANKS
·
Feb 20

Traws Pharma Highlights Positive Ratutrelvir Phase 2 COVID-19 Data

TIPRANKS
·
Feb 19

Morgan Stanley Keeps Their Buy Rating on BioNTech SE (BNTX)

TIPRANKS
·
Feb 17

Warburg Research Keeps Their Hold Rating on Deutsche Boerse (0H3T)

TIPRANKS
·
Feb 12

Braskem Files February 2026 Form 6-K, Reiterates Risk Warnings on Alagoas Event and COVID-19

TIPRANKS
·
Feb 10

Schaeffler India Announces Resignation of Non-Executive Director Andreas Schick

TIPRANKS
·
Feb 07

Pfizer and BioNTech Pause modRNA Shingles Ambitions

TIPRANKS
·
Feb 05

Jiangsu Sinopep-Allsino Biopharmaceutical Gets Good Manufacturing Practice Certificate for COVID-19 Drug Raw Material

MT Newswires Live
·
Feb 04

BioNTech Shares Lower After Leerink Partners Downgrade

MT Newswires Live
·
Feb 03

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Feb 03

BioNTech SE (BNTX) Gets a Buy from Morgan Stanley

TIPRANKS
·
Feb 02

Assessing BioNTech (BNTX) Valuation After Goldman Sachs Buy Upgrade And Oncology Growth Focus

Simply Wall St.
·
Feb 02

Leerink Partners Downgrades BioNTech to Market Perform From Outperform, Adjusts Price Target to $113 From $112

MT Newswires Live
·
Feb 02

Commerzbank (0RLW) Gets a Hold from Warburg Research

TIPRANKS
·
Feb 02

BioNTech Se : Leerink Partners Cuts to Market Perform From Outperform; Raises Target Price to $113.00 From $112.00

THOMSON REUTERS
·
Feb 02

BioNTech and Bristol-Myers Squibb Advance Pumitamig Trial in Aggressive Brain Cancer

TIPRANKS
·
Jan 31

Andreas de Wit Bought 11% More Shares In De.mem

Simply Wall St.
·
Jan 30

De.mem Director Increases Shareholding Through Core Chemicals Funding Placement

TIPRANKS
·
Jan 29